Molecular Partners AG (MOLN)

Molecular Partners AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	4.97	7.04	189.6	9.75
Revenue Growth (YoY)	-	-29.38%	-96.29%	1843.82%	4.39%
Gross Profit	-	4.97	7.04	189.6	9.75
Selling, General & Admin	15.24	17.58	19.36	22.24	17.45
Research & Development	40.19	48.6	48.78	50.75	55.72
Other Operating Expenses	2.69	-	-	-	-
Total Operating Expenses	58.12	66.19	68.15	72.99	73.17
Operating Income	-58.12	-61.22	-61.11	116.61	-63.42
Interest Income	1.52	7.21	4.28	1.86	0.19
Interest Expense	-5.05	-0.04	-5.16	-0.62	-0.56
Total Non-Operating Income (Expense)	-3.53	7.18	-0.88	1.24	-0.37
Pretax Income	-61.65	-54.04	-61.98	117.85	-63.78
Provision for Income Taxes	-0	-0	-	-	-0
Net Income	-61.65	-54.04	-61.98	117.85	-63.79
Net Income to Common	-61.65	-54.04	-61.98	117.85	-63.79
Shares Outstanding (Basic)	37	34	33	32	31
Shares Outstanding (Diluted)	37	34	33	33	31
Shares Change (YoY)	9.52%	3.85%	-1.49%	7.29%	24.02%
EPS (Basic)	-1.65	-1.59	-1.89	3.63	-2.06
EPS (Diluted)	-1.65	-1.59	-1.89	3.54	-2.06
Free Cash Flow	-51.97	-59.95	-59.58	117.39	-91.89
Free Cash Flow Per Share	-1.39	-1.76	-1.82	3.53	-2.96
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-1231.73%	-868.26%	61.50%	-650.17%
Profit Margin	-	-1087.38%	-880.70%	62.16%	-653.94%
FCF Margin	-	-1206.30%	-846.55%	61.91%	-942.03%
EBITDA	-55.98	-58.85	-58.69	119	-60.85
EBITDA Margin	-	-1184.06%	-833.87%	62.76%	-623.88%
EBIT	-58.12	-61.22	-61.11	116.61	-63.42
EBIT Margin	-	-1231.73%	-868.26%	61.50%	-650.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q